Pharmaceutical Executive October 17, 2024
Slope’s CEO and co-founder discusses technological advances that are solving problems with data collection and sorting from clinical trials.
Clinical trial sites produce massive amounts of data, all of which is important. Thankfully, new technologies are helping pharma companies sort through this data much more efficiently. Rust Felix, CEO and co-founder of Slope, spoke with Pharmaceutical Executive about some of these new technological advances.
Pharmaceutical Executive: How much have Pharma companies struggled with managing data from clinical trials in the past?
Rust Felix: Sponsors have historically grappled with major challenges in managing study data, particularly when it comes to biospecimens. Ensuring sites have the lab kits and supplies they need in order to collect samples from patients is just the first...
Today's Sponsors
Today's Sponsor